These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9742086)

  • 1. Regulation of Mdm2-directed degradation by the C terminus of p53.
    Kubbutat MH; Ludwig RL; Ashcroft M; Vousden KH
    Mol Cell Biol; 1998 Oct; 18(10):5690-8. PubMed ID: 9742086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
    Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
    J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
    Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
    Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization is required for p53 to be efficiently ubiquitinated by MDM2.
    Maki CG
    J Biol Chem; 1999 Jun; 274(23):16531-5. PubMed ID: 10347217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
    Gu J; Nie L; Wiederschain D; Yuan ZM
    Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation.
    Wang C; Ivanov A; Chen L; Fredericks WJ; Seto E; Rauscher FJ; Chen J
    EMBO J; 2005 Sep; 24(18):3279-90. PubMed ID: 16107876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain.
    Bernard X; Robinson P; Nominé Y; Masson M; Charbonnier S; Ramirez-Ramos JR; Deryckere F; Travé G; Orfanoudakis G
    PLoS One; 2011; 6(10):e25981. PubMed ID: 22046250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6.
    Marston NJ; Jenkins JR; Vousden KH
    Oncogene; 1995 May; 10(9):1709-15. PubMed ID: 7753547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MDM2 RING-finger domain is required to promote p53 nuclear export.
    Geyer RK; Yu ZK; Maki CG
    Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor p53 and the oncoprotein simian virus 40 T antigen bind to overlapping domains on the MDM2 protein.
    Brown DR; Deb S; Muñoz RM; Subler MA; Deb SP
    Mol Cell Biol; 1993 Nov; 13(11):6849-57. PubMed ID: 8413278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the degradation function of Mdm2.
    Kubbutat MH; Ludwig RL; Levine AJ; Vousden KH
    Cell Growth Differ; 1999 Feb; 10(2):87-92. PubMed ID: 10074902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
    Freedman DA; Levine AJ
    Mol Cell Biol; 1998 Dec; 18(12):7288-93. PubMed ID: 9819415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
    O'Keefe K; Li H; Zhang Y
    Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.
    Sionov RV; Coen S; Goldberg Z; Berger M; Bercovich B; Ben-Neriah Y; Ciechanover A; Haupt Y
    Mol Cell Biol; 2001 Sep; 21(17):5869-78. PubMed ID: 11486026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical and functional interactions between PML and MDM2.
    Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
    J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover.
    Dumaz N; Milne DM; Jardine LJ; Meek DW
    Biochem J; 2001 Oct; 359(Pt 2):459-64. PubMed ID: 11583595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
    Gu J; Nie L; Kawai H; Yuan ZM
    Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
    Yin Y; Stephen CW; Luciani MG; Fåhraeus R
    Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
    Liu WL; Midgley C; Stephen C; Saville M; Lane DP
    J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.